Macrogenics reported $47.33M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbvie ABBV:US $ 6098M 3648M
Amgen AMGN:US $ 6528M 1461M
AstraZeneca AZN:LN 5762M 567M
Biogen BIIB:US $ 1749.3M 512.1M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Daiichi Sankyo 4568:JP Y 662477M 85182M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Epizyme EPZM:US $ 77.42M 20.92M
Genmab GEN:DC DK 9071M 114M
Geron GERN:US $ 31.32M 3.55M
Gilead Sciences GILD:US $ 4296M 1042M
Immunogen IMGN:US $ 437.66M 41.09M
Johnson & Johnson JNJ:US $ 1579M 322M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Macrogenics MGNX:US $ 47.33M 76.14M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Pfizer PFE:US $ 2470M 526M
Puma Biotechnology PBYI:US $ 63.91M 0.78M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Seattle Genetics SGEN:US $ 261M 163.84M
Xencor XNCR:US $ 78.27M 65.21M